Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural calcitonin versus triamcinolone for degenerative spinal canal stenosis
IRCT20120814010599N24Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of TBRIA, triamcinolone and ropivacaine in spinal stenosis and lumbar spinal stenosis (LSS) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain score at 12 weeks and Function at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
TBRIAtriamcinoloneropivacaine
03
Conditions
spinal stenosislumbar spinal stenosis (LSS)
Beyond the preview
Go deeper on IRCT20120814010599N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120814010599N24.